About Us

Mission Statement

The mission of ACell is to develop, manufacture, and commercialize regenerative medicine products that improve patient care and provide better treatment outcomes in both the medical and veterinary markets.

Business Strategy

To build a superior regenerative medicine company and achieve our mission, the business strategy adopted by ACell is to:

Continue to develop, refine, and leverage our biological scaffold technology to create innovative new products and applications
Increase awareness of regenerative medicine/tissue engineering and the ACell products by providing superior education and training programs
Build and maintain quality production facilities capable of supporting worldwide product distribution
Develop key alliances with strategic partners in order to most efficiently and effectively market, distribute, and sell our products
Provide the industry's best service and value-added support to customers and strategic partners
Maximize shareholder value by providing cost-effective products that leverage our experience, knowledge, and technology